Advanced search
Publication Cover
Therapeutics and Clinical Risk Management Volume 14, 2018 - Issue
Submit an article Journal homepage
69
Views
10
CrossRef citations to date
0
Altmetric
Original Research

Identifying a subpopulation with higher likelihoods of early response to treatment in a heterogeneous rare disease: a post hoc study of response to teduglutide for short bowel syndrome

Kristina S Chen1 Outcomes Research and Epidemiology, Shire Human Genetic Therapies, Inc., Cambridge, MA, USA, [email protected]Correspondence[email protected]
,
Jipan Xie2 Analysis Group, Inc., Los Angeles, CA, USA
,
Wenxi Tang3 Analysis Group, Inc., New York, NY, USA
,
Jing Zhao4 Analysis Group, Inc., Boston, MA, USA
,
Palle B Jeppesen5 Department of Medical Gastroenterology, Rigshospitalet, Copenhagen, Denmark
&
James E Signorovitch4 Analysis Group, Inc., Boston, MA, USA
Pages 1267-1277 | Published online: 25 Jul 2018

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.